A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
Recruiting · NCT07730190 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors | Advanced Malignancies | Recruiting | Phase 1 | 2026-09-15 | NCT07730190 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 16 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Provincial Hospital | Fuzhou | China | 19 |
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Henan Cancer Hospital | Zhengzhou | China | 57 |
| Hunan Cancer Hospital | Changsha | China | 123 |
| Peking University First Hospital | Beijing | China | 163 |
| Renji Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai | China | 18 |
| The First affiliated Hospital of Anhui Medical University | Hefei | China | 56 |
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 33 |